| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| PepGen Inc. | EVP, Res. & Preclin. Dev. | Stock Option (Right to Buy) | 144K | 24 Mar 2023 | Direct | ||
| PepGen Inc. | EVP, Res. & Preclin. Dev. | Common Stock | 0 | $4.17 | 24 Mar 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| PEPG | PepGen Inc. | 24 Mar 2023 | 3 | -$3.58K | 4 | EVP, Res. & Preclin. Dev. | 28 Mar 2023, 19:36 |
| PEPG | PepGen Inc. | 01 Mar 2023 | 1 | $0 | 4 | EVP, Res. & Preclin. Dev. | 02 Mar 2023, 15:46 |
| PEPG | PepGen Inc. | 06 Feb 2023 | 9 | -$37.4K | 4 | EVP, Res. & Preclin. Dev. | 08 Feb 2023, 16:42 |
| PEPG | PepGen Inc. | 06 May 2022 | 1 | $0 | 4 | Ex. VP. Research & Preclinical Development | 10 May 2022, 18:47 |
| PEPG | PepGen Inc. | 05 May 2022 | 0 | $0 | 3 | Ex. VP. Research & Preclinical Development Exhibit 24: Power of Attorney | 05 May 2022, 20:31 |